The chemical substance known as "4-[(4-{[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazol-1-yl]carbonyl}piperazin-1-yl)acetyl]morpholine hydrochloride" with CAS number 870007-79-7 is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as piperazine, morpholine, and imidazole. This compound is typically classified as a pharmaceutical agent, potentially exhibiting biological activity due to its structural features that may interact with specific biological targets. Its hydrochloride salt form indicates enhanced solubility in aqueous environments, which is often advantageous for drug formulation and delivery. The presence of bulky groups, such as tert-butyl and chlorophenyl moieties, suggests potential lipophilicity, influencing its pharmacokinetic properties. Additionally, the stereochemistry indicated by the (4S,5R) configuration may play a crucial role in its biological activity and interaction with receptors or enzymes. Overall, this compound's unique characteristics make it a subject of interest in medicinal chemistry and drug development.

4-[(4-{[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazol-1-yl]carbonyl}piperazin-1-yl)acetyl]morpholine hydrochloride

870007-79-7: The chemical substance known as "4-[(4-{[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazol-1-yl]carbonyl}piperazin-1-yl)acetyl]morpholine hydrochloride" with CAS number 870007-79-7 is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as piperazine, morpholine, and imidazole. This compound is typically classified as a pharmaceutical agent, potentially exhibiting biological activity due to its structural features that may interact with specific biological targets. Its hydrochloride salt form indicates enhanced solubility in aqueous environments, which is often advantageous for drug formulation and delivery. The presence of bulky groups, such as tert-butyl and chlorophenyl moieties, suggests potential lipophilicity, influencing its pharmacokinetic properties. Additionally, the stereochemistry indicated by the (4S,5R) configuration may play a crucial role in its biological activity and interaction with receptors or enzymes. Overall, this compound's unique characteristics make it a subject of interest in medicinal chemistry and drug development.

CAS 870007-79-7

4-[(4-{[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dihydro-1H-imidazol-1-yl]carbonyl}piperazin-1-yl)acetyl]morpholine hydrochloride